5-Bromo-3-(trifluoromethyl)isothiazole-4-carboxylic acid, 98%, 1g

N-(2-(ETHYLAMINO)ETHYL)-2,2,2-TRIFLUOROACETAMIDE, 95.0%, 1g

(3-Chloro-4-(diethylcarbamoyl)phenyl)boronic acid, 95.0%, 1g

3-[(4-chloro-3-methylphenoxy)methyl]-4,5-dihydro-1H-1,2,4-triazole-5-thione, 95%, 100mg

4-Hydroxythiophene-2-carboxylic acid, 97%, 250mg

CHloro(cyclopentadienyl)(triphenylphosphine)nickel(II), 97%, 5g

2-Cyclopropylthiazole-4-carbaldehyde, 97%, 10g

4-Chloroacetyl-piperazine-1-carboxylic acid tert-butyl ester, 98.0%, 1g

9-methyl-9H-fluorene-9-carboxylic acid, 95.0%, 250mg

2,2'-(Piperazine-1,4-diyl)bis(N-methyl-N-(4-nitrophenyl)acetamide) (Nintedanib Impurity), 97%, 50mg

2,3-(Methylenedioxy)benzaldehyde>97.0%(GC)1g

Dibenzofuran, 98.0%, 10g

Ácido kójico, >98 %, para bioquímica, 10 g, envase de vidrio